Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-02-11

FDA Approved: EDEX — Supplemental Application (Endo USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for EDEX (alprostadil) from Endo USA, Inc., authorizing changes to the product's labeling and approved use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EDEX (ALPROSTADIL)

Snippet

SUPPL AP for EDEX (ALPROSTADIL)